RussianPatents.com

Derivatives of aminothiols

Derivatives of aminothiols
IPC classes for russian patent Derivatives of aminothiols (RU 2265608):
Another patents in same IPC classes:
Electroluminescent material containing organic luminescent substance Electroluminescent material containing organic luminescent substance / 2265040
Invention provides novel electroluminescent material comprised of injecting layer, metal chelate complex-based active luminescent layer, hole-transition layer and hole-injecting layer. Luminescent substance is selected from oxyquinolate metallocomplexes of zinc 8-hydroxy-2-methoxyquinolate and zinc 8-hydroxy-2-methylquinolate. Electroluminescent material shows emission in green spectrum region.
Method for preparing bis-(1-vinylimidazole)zinc diacetate / 2254337
Invention relates to the improved method for preparing the chelate compound bis-(1-vinylimidazole)zinc diacetate (I) representing the medicinal preparation of acizol that is the effective antidote and antioxidant. Method for preparing the compound (I) is carried out in the absence of organic solvents at temperature 20-35°C in the mole ratio 1-vinylimidazole : zinc diacetate in the range from 10:1 to 3:1. Method provides exclusion fire hazard and explosion hazard solvent from the technological process and enhancement of the yield of highly pure acizol satisfied for Pharmacopoeia requirements.
Method of jointly preparing 2-alkylidenemagnesiumcyclopentanes and 2-alkyl-3-methylidenemagnesiumcyclopentanes Method of jointly preparing 2-alkylidenemagnesiumcyclopentanes and 2-alkyl-3-methylidenemagnesiumcyclopentanes / 2245885
Invention relates to preparation of novel organomagnesium compounds, which consists in reaction of alkylallenes with diethylmagnesium in presence of zirconacene dichloride as catalyst used in amount 0.2 to 0.6 mmole based on alkylallene in diethyl ether medium under argon atmosphere, reaction time being 8-12 h.
The method of obtaining 1,6-dialkyl-2,5-bis(atalanta)-1,5 - hexadiene The method of obtaining 1,6-dialkyl-2,5-bis(atalanta)-1,5 - hexadiene / 2238942
The invention relates to a method of obtaining new magyarkanizsa compounds which may find application as components of catalytic systems in the processes of oligo - and polymerization of olefin, diene and acetylene hydrocarbons, and fine organic and ORGANOMETALLIC syntheses
A method of producing metals dimethyldithiocarbamate A method of producing metals dimethyldithiocarbamate / 2215743
The invention relates to petrochemistry, specifically to the production dialkyldithiocarbamate accelerators of vulcanization of rubbers
The method of obtaining organosiloxane silanes / 2211840
The invention relates to the chemistry of organosilicon compounds, in particular to methods for organoselenium silanes, and can be used to obtain silicone fluids and resins of various types
A method of obtaining a metal-containing derivatives of bacteriochlorophyll, new metilirovannye derivatives bacteriochlorophyll, the pharmaceutical composition A method of obtaining a metal-containing derivatives of bacteriochlorophyll, new metilirovannye derivatives bacteriochlorophyll, the pharmaceutical composition / 2193038
The invention relates to a new method of obtaining metallizovannyh derived bacteriochlorophyll for use in the methods of photodynamic therapy (PDT) and in vivo diagnostics and photodynamic destruction of viruses and microorganisms in vitro, as well as some new metallosalen derived bacteriochlorophyll
Cobalt octasulfooctaphenyltetrapyrazinoporphyrazine Cobalt octasulfooctaphenyltetrapyrazinoporphyrazine / 2265026
Invention relates to preparing compounds of tetrapyrazinoporphyrazine order, namely, to cobalt octasulfooctaphenyltetrapyrazinoporphyrazine of the formula:
Metal complexes of tetra-(tri-5,6,8-carboxy)- anthraquinonoporphyrazine Metal complexes of tetra-(tri-5,6,8-carboxy)- anthraquinonoporphyrazine / 2264407
Invention relates to new derivatives of metalloporphyrazines, namely to metal complexes of tetra-(tri-5,6,8-carboxy) -anthraquinonoporphyrazine of the general formula:
Metal complexes of tetra-(tri-5,6,8-methyl)-anthraquinonoporphyrazine Metal complexes of tetra-(tri-5,6,8-methyl)-anthraquinonoporphyrazine / 2264406
Invention relates to new derivatives of metalloporphyrazines, namely: to metal complexes of tetra-(tri-5,6,8-methyl)-anthraquinonoporphyrazine of the general formula:
Method for preparing ferrous (ii) acetate Method for preparing ferrous (ii) acetate / 2259994
Invention relates to a method for preparing acetic acid salts, in particular, anhydrous ferrous (II) acetate. Method for preparing anhydrous ferrous (II) acetate involves interaction of metallic iron with acetic acid in the presence of oxidizing agents of ferric oxide Fe2O3 or Fe3O4 and molecular iodine in the mole ratio acetic acid : acetic anhydride : iron oxide = 100:(6-20):(2-2.5), respectively, and in the mole ratio iron oxide : iodine = 100:6.3. The process is carried out at temperature 80°C in the beaded mill of vertical type with high-rotation blade mixer and reflux condenser in the mass ratio of glass beads and liquid phase in the charge = 1:1. The process is carried out with periodic taking off samples of the end product solid phase by filtering and the following recover filtrate and feeding with acetic acid and iron oxide. For compensation of components loss of liquid phase in filtering there are recovered into reactor to the repeated process that is carried out for four times at a time. All procedures of the basic process and filtration are carried out in nitrogen medium. Preferably, method involves using hematite, γ-oxide, iron minium, magnetite or Fe3O4 x 4 H2O as the iron oxide source. Invention provides possibility for preparing anhydrous ferrous (II) acetate and simplifying method due to excluding the evaporation stage in isolation of salt.
Organocobalt complexes with tridentate schiff's bases as initiators of emulsion polymerization and copolymerization of diene and vinyl monomers Organocobalt complexes with tridentate schiff's bases as initiators of emulsion polymerization and copolymerization of diene and vinyl monomers / 2257377
Invention relates to alkylcobalt(III) complexes with tridentate Schiff's bases wherein alkyl ligand contains functional group, notably hydroxyl, carboxyl, or amino group, in accordance with general formula:
Heterometallic neodymium (iii) and iron (iii) malate and a method for preparation thereof Heterometallic neodymium (iii) and iron (iii) malate and a method for preparation thereof / 2255082
Invention provides heterometallic neodymium (III) and iron (III) malate having formula I:
Metal-complexes of tetra-6-carboxy-antthraquinone porphyrazine Metal-complexes of tetra-6-carboxy-antthraquinone porphyrazine / 2254336
Invention relates to new derivatives of metalloporphyrazines of the general formula (I):
Method for scouring of blast furnace, two-component immobilized catalyst for ethylene polymerization, method for production the same (variants), and method for production of polyethylene using this catalyst Method for scouring of blast furnace, two-component immobilized catalyst for ethylene polymerization, method for production the same (variants), and method for production of polyethylene using this catalyst / 2248374
Claimed catalyst includes alumina, mixture of transition metal complexes with nitrogen skeleton ligands (e.g., iron chloride bis-(imino)pyridil complex and nickel bromide bis-(imino)acetonaphthyl complex). According the first embodiment catalyst is prepared by application of homogeneous mixture of transition metal complexes onto substrate. iron chloride bis-(imino)pyridil complex and nickel bromide bis-(imino)acetonaphthyl complex (or vise versa) are alternately applied onto substrate. According the third embodiment catalyst is obtained by mixing of complexes individually applied onto substrate. Method for polyethylene producing by using catalyst of present invention also is disclosed.
Method for scouring of blast furnace, two-component immobilized catalyst for ethylene polymerization, method for production the same (variants), and method for production of polyethylene using this catalyst Method for scouring of blast furnace, two-component immobilized catalyst for ethylene polymerization, method for production the same (variants), and method for production of polyethylene using this catalyst / 2248374
Claimed catalyst includes alumina, mixture of transition metal complexes with nitrogen skeleton ligands (e.g., iron chloride bis-(imino)pyridil complex and nickel bromide bis-(imino)acetonaphthyl complex). According the first embodiment catalyst is prepared by application of homogeneous mixture of transition metal complexes onto substrate. iron chloride bis-(imino)pyridil complex and nickel bromide bis-(imino)acetonaphthyl complex (or vise versa) are alternately applied onto substrate. According the third embodiment catalyst is obtained by mixing of complexes individually applied onto substrate. Method for polyethylene producing by using catalyst of present invention also is disclosed.
Tetra-6-(para-sulfophenylene)-anthraquinone porphyrazine metal chelates Tetra-6-(para-sulfophenylene)-anthraquinone porphyrazine metal chelates / 2246495
Invention relates to new derivatives of metalloporphyrazine of the general formula (I): wherein M means Cu, Co. These compounds can be used as dyes, catalysts in different processes and materials of sensitive members of gas sensor.
Performancecriteria connection, the retrieval method (variants) and a pharmaceutical preparation containing these compounds Performancecriteria connection, the retrieval method (variants) and a pharmaceutical preparation containing these compounds / 2242477
The invention relates to the objects of the invention characterized in the claims, i.e

FIELD: organic chemistry, medicine, physiology.

SUBSTANCE: invention relates to agents for regulation (maintaining or suppression) of physical working ability and/or adaptation to different variants represented by solvated complex compounds of the general formula (I): Katm+[L1qEL2]Ann- x p.Solv (I) wherein L1 means aminothiols of the formula: R1NHCH(R2)(CH2)1-2SR3 wherein R1 means hydrogen atom (H), (C1-C20)-alkyl or RCO; R means (C1-C19)-alkyl; R2 means H or carboxyl; R3 means H, (C1-C20)-alkyl, (C2-C20)-alkenyl or benzyl; q = 1, 2 or 3; L2 means halogen atom, water and/or organic ligand. For example, bis-(N-acetyl-L-cysteinato)aquozinc (II) diheptahydrate suppresses physical working ability and in the dose 50 mg/kg increases reviving time of mice by 6 times and cats - by 2.8fold under conditions of acute hypoxia with hypercapnia, and increases reviving time of mice by 4 times under conditions of acute hypobaric hypoxia. Under the same conditions the known antihypoxic agents amtizol, acizol or mexidol are inactive or less active significantly by their activity. Bis-(N-acetyl-L-cysteinato)-ferrous (II) pentahydrate is more active as compared with the known antihypoxic agents and protects experimental animals in 4 variants of hypoxia. Bis-(N-acetyl-L-cysteinato)zinc (II) sulfate octahydrate is similar to enumerated compounds by its antihypoxic activity.

EFFECT: valuable medicinal properties of compounds.

4 cl, 1 dwg, 11 tbl, 33 ex

 

The invention relates to new compounds of the number of complex compounds of bimetallic with, in particular, biological activity and which may find use as pharmaceuticals.

It is well known that the high biological activity of trace elements is determined by their biochemical function in the structure of enzymes and enzyme systems as working tools last. Some contribution to their biological activity have also been low-molecular-weight metabolites. Efficiency coming from outside in the animal organism of trace elements is largely determined by the presence in the digestive tract of suitable ligands necessary for their biological transport. Low molecular weight metabolites of trace elements, which is equal to the right can be considered as metabolites of organic ligands, can simultaneously perform the function of protecting the body from exposure to a variety of alien factors physical, chemical or biological nature. These facts collectively formed the basis of the scientific basis for the development of complex compounds of Bioelements multi-purpose [1-3].

One of the most suitable ligands for the complex compounds of Bioelements for medical purposes can be considered natural aminothio the s. These compounds find property good chelators and play a very important role to control the thiol-disulfide equilibrium in biological systems. Therefore, complex compounds of Bioelements with aminosilane can be considered as prodrugs in relation not only to bioelement, but also to the ligand, and the most durable of them as self-medication purposes. This idea has not yet been expressed in the form of a systematic experimental study, however, you can specify on a separate development of this plan. Thus, in the patent [4] described a group of precursors of glutathione, including the form of complex compounds with some Bioelements, based on ideas about the important role of glutathione in the regulation of biochemical thiol-disulfide balance.

However, the cited work does not exhaust the possible choices as ligands, and the bio-elements and methods for their inclusion in the design of complex compounds. In addition, in this paper when discussing the possible beneficial role of compounds aminothiols lists only some pathological situation and says nothing about their useful manifestations in extreme situations and in normal physiology.

The task of this invention are new chemical compounds having, in particular, biological engineering is th activity.

This problem is solved derived aminothiols General formula I

Katm+[L1qL2]Ann.p.Solv,

where L1- aminothiol R1NHCH(R2)(CH2)1-2SR3and where R1is hydrogen, alkyl (C1-20or the group RCO, R is alkyl (C1-19; R2is hydrogen or carboxyl, R3is hydrogen, alkyl With1-20alkenyl2-20or benzyl, and q can take values 1, 2 or 3;

L2- halogen, water and/or organic ligand from among substituted by one or two alkilani1-20one or two hydroxy or oxymethylene groups, pyridine, hydroxy coumarin derivatives, nicotinic, p-aminobenzoic, phenylacetic acid, or ascorbic acid, or arginine;,

E-Cu(I), CA(II), Co (II), Cu (II), Fe(II), Mn(II), Ni (II), Zn(II)

Co (III), Cr (III), Ge(IV), Ti (IV), V(IV);

Kat is absent or represented by a cation 2-ethyl-6-methyl-3-hydroxypyridine or inorganic cation of an alkaline or alkaline-earth metal;

An absent or represented by the anion of p-toluenesulfonic acid or sulfate;

Solv - water, and R can take values from 0 to 8.5;

m can take values from 0 (with the exception of compound I, where R1- CH3CO, R2- COO, L2- no, n - 0, p - 0) to 2;

n can take values from 0 to 3.

Preferred are compounds I, where

L1- N-acetyl-L-sistei is; L2- water, e - Zn(II), q - 2; R - 2,5; m=n=0,

or the compounds I, where L1- N-acetyl-L-cysteine; L2no, e - Fe(II); q - 2; p - 5; m=n=0,

or the compounds I, where L1- N-acetyl-L-cysteine; L otsutstvuet, e - Zn (II), q - 2; An - sulfate; p - 8; m is 0; n is 2.

The synthesis of compounds of General formula (I) can be any of the known literature methods. In this patent the development of these selected only those that are either not accompanied by the formation of by-products, or may result in the formation of volatile products that are easy to catch. The General method consists of mixing calculated amounts of reactants in water or in aqueous alcohol at a temperature of 20-80°until the reaction is completed. Then the solvent and volatile products of the reaction is distilled off in vacuum and bring the residue to constant weight.

The following examples illustrate the synthesis of compounds according to the invention and their biological activity.

Example 1. N-Acetyl-L-cysteinato(akvo)zinc (II) disabilitati.

Mixed 3.00 g of N-acetyl-L-cysteine and a 4.03 g of the acetate of zinc (II) dihydrate in 15 ml of water at 18-20°To increase the temperature of the reaction medium up to 60°C and stirred at this temperature for 1.5 hours. Then distilled water acetic acid under vacuum (10-15 Torr) and bring the residue to constant weight. Exit 5, 27, Trasl. 252°C. Found, %: C 20,47; H5,09; N 4,62. C5H9NO4SZn. 2,5 H2O. Calculated, %: C 20,74; N To 4.87; N 4,84.

Example 2. N-Acetyl-L-cysteinato(akvo)cobalt(II)]tetracampidae.

Mixed 3.00 g of N-acetyl-L-cysteine and 4,58 g of cobalt acetate(II) tetrahydrate in 15 ml of water at 18-20°To increase the temperature of the reaction medium up to 60°C and stirred at this temperature for 1.5 hours. Then distilled water acetic acid under vacuum (10-15 Torr) and bring the residue to constant weight. The yield of 6.52, So different. 64-66°C. Found, %: C 18,56; N. Of 5.81; N 4,18. C5H9NO4S2Co.4,5 H2O. Calculated, %: C 18,81; N. Of 5.68; N 4,39.

Example 3. N-Acetyl-L-systemnational(III).

Mix of 5.00 g of N-acetyl-L-cysteine and 8,19 g to Balt(III)examineralfred in 70 ml of water at 60°and incubated for 3.5 hours at 18-20°C. Then evaporated to about 50 ml of aqueous ammonia under vacuum (10-15 Torr), separating the precipitated product by filtration, washed his 15-20 ml of water and brought to a constant weight. The yield of 6.71, So different. 227°C. Found, %: C 27,12; N 2,79; N 6,52. With5H6NO3SCo. Calculated, %: 27,41; N Was 2.76; N 6,39.

Example 4. N-Acetyl-L-cysteinato (akvo) copper (I) semihydrate.

Mix is 4.21 g of N-acetyl-L-cysteine and 1.84 g of copper oxide (I) in 8 ml of water and stirred for 1.5-2 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. The yield of 6.52, Trasl. 136°C. Found, %: C 23,47; N 4,51; N 5,38. C5H10NO4 SCu. 0,5H2O. Calculated, %: C 23,76; N. Of 4.66; N Of 5.05.

Example 5. Bis(N-acetyl-L-cysteinato)equating(II) disabilitati.

Mix of 5.00 g of N-acetyl-L-cysteine and to 3.36 g of the acetate of zinc(II) dihydrate in 20 ml of water at 18-20°To increase the temperature of the reaction medium up to 60°C and stirred at this temperature for 0.5 hours. Then distilled water acetic acid under vacuum (10-15 Torr) and bring the residue to constant weight. Exit 7, 33, So different. 112-118°C. Found, %: C 26,22; N 5,44; N 6,37. C10H16N2O6S2Zn. 2,5 H2O. Calculated, %: C 26,53; N 5,12; N Is 6.19.

Example 6. Bis(N-acetyl-L-cysteinato) cobalt (II) tricameral.

Mix of 5.00 g of N-acetyl-L-cysteine and 3,82 g of cobalt acetate (II) tetrahydrate in 20 ml of water at 18-20°To increase the temperature of the reaction medium up to 60°C and stirred at this temperature for 1.5 hours. Then distilled water acetic acid under vacuum (10-15 Torr). Output for 6.81, Trasl. 56°C. Found, %: C 26,42; N 5,42, N 5,93. With10H16H2O6S2With. 3,5H2O. Calculated, %: C 26,91; N 5,19; N 6,28.

Example 7. Bis (N-acetyl-L-cysteinato) cobalt (III) trihydrate.

Mix of 6.00 g of N-acetyl-L-cysteine and to 4.92 g of cobalt(III)examineralfred in 30 ml of water at 50°and incubated for 3.5 hours at 18-20°C. and Then distilled water ammonia under vacuum (10-15 Torr), separating the precipitated product by filtration and washed it 10-15 ml of water and bring the OS is atok until constant weight. Output 10,89, Trasl. 111°C. Found, %: C 27,22; N 5,23; N OF 6.31 .C10H15N2O6S2Co.3 H2O. Calculated, %: C 27,53; N Is 4.85; N, 6.42 Per.

Example 8. Bis(N-acetyl-L-cysteinato)manganese(II) pentahydrate.

Mix of 5.00 g of N-acetyl-L-cysteine and 3.75 g of manganese acetate(II) tetrahydrate in 20 ml of water at 18-20°With, bring bring the temperature of the reaction medium up to 60°C and stirred at this temperature for 1.5 hours. Then distilled water acetic acid under vacuum (10-15 Torr) and bring the residue to constant weight. The output of 7.25, Trasl. 76°C. Found, %: C 25,42; N 5,70; N 6,11. C10H16N2O6S2Mn. 5H20. Calculated, %: C 25,59; N To 5.58; N 5,97.

Example 9. Bis (N-acetyl-L-cysteinato) iron (II) pentahydrate.

Mix of 5.00 g of N-acetyl-L-cysteine and 3.77 g of the acetate of iron (II) tetrahydrate in 20 ml of water at 18-20°To increase the temperature of the reaction medium up to 60°C and stirred at this temperature for 1.5 hours. Then distilled water acetic acid under vacuum (10-15 Torr) and bring the residue to constant weight. Output 7,16, So different. 113°C. Found, %: C 25,07; N 5,42; N 5,61. C10H16N2O6S2Fe. 5H2O. Calculated, %: C 25,54; N 5,69; N 5,96.

Example 10. Bis (2-methyl-5-ethyl-3-hydroxypyridine) bis (N-acetyl-L-cysteinato)-acculturation (IV) tetracampidae.

Mix of 5.00 g of N-acetyl-L-cysteine, 2,73 g esculetin and 4,20 g 2-methyl-5-ethyl-3-is hydroxypyridine with 15,32 millimole hydrated Titanic acid in 30 ml of water at 18-20° With increase of the temperature of the reaction medium up to 60°C and stirred at this temperature for 2.5 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 13,81, So different. 124°C. Found, %: C 46,25; N 6,01; N 6,18. C35H42N4O12S2Ti. 4,5H2O. Calculated, %: C 46,51; N 5,69; N 6,20.

Example 11. Bis(N-acetyl-L-cysteinato) acculturation (IV).

Mix 5.0 g of N-acetyl-L-cysteine, 2,73 g esculetin and 15,32 millimole hydrated Titanic acid in 30 ml of water at 18-20°To increase the temperature of the reaction medium up to 60°C and stirred at this temperature for 2.5 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 8,46 was So different. 112°C. Found, %: C 41,32; N 4,01; N 4,86. C19H20N2O10S2Ti. Calculated, %: C 41,61; N 3,68; N 5,11.

Example 12. Magnesium bis(N-acetyl-L-cysteinato) acculturation(IV) trihydrate

Mix 3.25 g of N-acetyl-L-cysteine, 1,77 g esculetin and 0.40 g of magnesium oxide from 9.46 to millimole hydrated Titanic acid in a mixture of 15 ml of water and 5 ml of alcohol at 18-20°To increase the temperature of the reaction medium up to 60°C and stirred at this temperature for 2 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 6,21 was So different. 94°C. Found, %: C 36,22; N. Of 3.25; N 4,62. C19H18N2O10S22O. Calculated, %: C 36,53; H 2,90; N 4,48.

Example 13. Magnesium bis (N-acetyl-L-cysteinato)bis (esculenta)titanium(IV) pentahydrate.

Mix of 5.00 g of N-acetyl-L-cysteine, 5,46 g esculetin and 0.62 g of magnesium oxide with 15,32 millimole hydrated Titanic acid in a mixture of 25 ml of water and 5 ml of alcohol at 18-20°To increase the temperature of the reaction medium up to 60°C and stirred at this temperature for 2.5 hours. Then distilled water alcohol under vacuum (10-15 Torr) and bring the residue to constant weight. Output 12,88 was So different. 108°C. Found, %: C 39,69; N 3,12; N 3,11. C28H24N2O14S2MgTi. 5H2O. Calculated, %: 40,09; N 2,88; 3,34 N.

Example 14. Bis(N-acetyl-L-cysteinato)germanium(IV) trihydrate.

Mix 5.0 g of N-acetyl-L-cysteine with 15,32 millimole hydrated germanium acid in 15 ml of water at 18-20°To increase the temperature of the reaction medium up to 60°C and stirred at this temperature for 2.5 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 6,87, Trasl. 152°C. Found, %: C 26,82; N To 4.62; N 6,02. C10H14N2O6S2Ge. 3H2O. Calculated, %: C 26,75; N. Of 4.49; N 6,24.

Example 15. Bis(S-allyl-L-homocysteine)calcium(II) trihydrate.

Mix 4,48 g S-allyl-L-homocysteine from 0.72 g of calcium oxide in 15 ml of water at 18-20°To increase the temperature of the reaction medium up to 60°and With mix PR is this temperature for 1 hour. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. The yield of 5.68, So different. Number 109-121°C. Found, %: C 37,64; N 7,02; N of 5.83. C14N24N2O4S2Ca. 3H2O. Calculated, %: C 37,99; N 6,83; N 6,33.

Example 16. Bis(S-benzyl-L-homocysteine)manganese(II) tetrahydrate.

Mix of 4.46 g of S-benzyl-L-homocysteine 2.43 g of manganese acetate (II) tetrahydrate in 15 ml of water at 18-20°With, bring the temperature of the reaction medium up to 60°C and stirred at this temperature for 2 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 5,70, So different. 96-117°Found, %: C 45,69, N 6,55; N of 4.83. C22H28N2O4S2Mn. 4H2O. Calculated, %: C 45,91; N 6,30; N 4,87.

Example 17. Sodium [N-acetyl-L-cysteinato(nicotinate)zinc (II) sulfate tetrahydrate.

Mix 1.73 g of N-acetyl-L-cysteine and 1.31 g of nicotinate and 3.06 g of zinc sulfate (II) heptahydrate in 15 ml of water at 18-20°With, then gradually added with stirring 0.56 g sodium, increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 1.5 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. The yield of 6.52, So different. 179°C. Found, %: C 23,96; N. Of 4.35; N 4,86. C11H13N2O9S2NaZn. 4H20. Calculated, %: 24,38; N 3,91; N 5,17.

Example 18. Bis(L-cysteinato)zinc(II) sulfate(that is ilat) octanamide.

Mix of 1.61 g of L-cysteine, 2,53 g of the monohydrate of p-toluenesulfonic acid, 1, 46 g of dihydrate zinc acetate(II) and of 2.27 ml, 24.4% of sulfuric acid in 15 ml of water at 18-20°With, then increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 1.5 hours. Distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 6,00 was So different. 74°C. Found, %: 26,34; N 5,43, N 6,17. C20H28N2O14S3Zn.8,5H2O. Calculated, %: 26,71; N 5,04; N 5,96.

Example 19. Cysteamine(pyridoxine)chlorotic(II) the uranyl.

Mix 1.20 g group probably facilitates hydrochloride, 1,79 g of pyridoxine hydrochloride and 2, 32 g of dihydrate zinc acetate(II) in 15 ml of water at 18-20°With, then increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 2 hours. Distilled water mixed with volatile acids in vacuum (10-15 Torr) and bring the residue to constant weight. The output of 4.77, So different. 166°C. Found, %: C 25,98; N 6,63; N by 5.87. C15H27N5O5S2Ni.7,5H2O. Calculated, %: 26,44; N To 6.43; N 6,17.

Example 20. Sodium D,L-methionate(p-aminobenzoate)copper(II) heptahydrate.

Mix 1.22 g of D,L-methionine, 1.12 g of p-aminobenzoic acid and 2.03 g of copper acetate(II) tetrahydrate in 15 ml of water at 18-20°With, then gradually added with stirring to 0.44 g of sodium, increase the temperature of the reaction mixture to 60°and mix With p and this temperature for 1.5 hours. Then distilled water acetic acid under vacuum (10-15 Torr) and bring the residue to constant weight. The yield of 6.52, Trasl. above 210°C. Found, %: C Of 28.72; N 3,12; N 5,86. C12H16N2O4SCuNa. 7H2O. Calculated, %: C 29,00; N 3,24; N 5,64.

Example 21. Bis [(D,L-methionate(L-cysteinato)chromium(III)] trisulfate octahedral.

Mix of 1.32 g of D,L-methionine, 1.07 g of L-cysteine and 3,17 g of sulfate of chromium(III) octadecahydrate in 15 ml of water at a temperature of 18-20°To increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 1 hour. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. The output value of 4.76, So different. 221°C. Found, %: C 17,36; N 3,18; N is 5.06. C16H36N4O20S7Cr2. 8H2O. Calculated, %: C 17,84; N 3,37; N 5,20.

Example 22. Cysteamine(L-arginine)Nickel (II) toilet heptageniidae.

Mix 1.18 g group probably facilitates hydrochloride, of 1.80 g of L-arginine, 1.97 g of the monohydrate of p-toluenesulfonic acid and 2.58 g of leads to compounds, which Nickel(II) tetrahydrate in 15 ml of water at 18-20°With, then increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 2 hours. Distilled water hydrogen chloride in vacuum (10-15 Torr) and bring the residue to constant weight. Output 6,38 was So different. 64°C. Found, %: C 29,12; N. Of 6.75; N 11,18. C15H27N5O5S2Ni. 7,5H2O. Calculated, %: 29,37; N 6,41; 11,42.

Example 23. L-Cysteinato (phenylacetate)vanadyl acidic uranyl sulfate.

Mix 1.44 g of L-cysteine, of 1.62 g of phenylacetate and 2, 58 g of the three-hydrate sulphate vanadyl in 15 ml of water at 18-20°With, then increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 1.5 hours. Distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. The output of 6.25 was So different. 71°C. Found, %: C 24,59; N the ceiling of 5.60; N 2,31. C11H16NO9S2V.6H2O. Calculated, %: C 24,96; N 5,33; N 2,64.

Example 24. Bis(N-acetyl-L-cysteinato)zinc(II) sulfate octahydrate.

Mix at 3.35 g of N-acetyl-L-cysteine from 2.95 g of zinc sulfate(II) heptahydrate in 15 ml of water at 18-20°With, then increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 2 hours. Distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 6,46 was So different. 163°C. Found, %: From 18.76; H 3,02; N 4,56. C10H18N2O10S3Zn.8H2O. Calculated, %: From 19.00; N 2,87; N 4,43.

Example 25. Disodium bis(N-acetyl-L-cysteinato)zinc(II) tetrahydrate.

Mix of 3.73 g of N-acetyl-L-cysteine and 2.51 g of the acetate of zinc(II) dihydrate in 15 ml of water at 18-20°With, then gradually added with stirring to 1.21 g soda, raise the temperature of the reaction mixture to 60°C and stirred at this temperature for 2 hours. Distilled water under vacuum (10-15 Torr) and bring the STATCOM to constant weight. Output 5,79 was So different. 166°C. Found, %: C 23,56; N To 2.57; N 5,31. C10H14N2O6S2Na2Zn.42O. Calculated, %: C 23,75; N To 2.79; N, 5,54.

Example 26. Sodium bis(N-acetyl-L-cysteinato)zinc(II) dihydrate.

Mix 3,93 g N-acetyl-L-cysteine and 2.64 g of the acetate of zinc(II) dihydrate in 15 ml of water at 18-20°With, then gradually added with stirring 0.64 g of soda, raise the temperature of the reaction mixture to 60°C and stirred at this temperature for 2 hours. Distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 5,42 was So different. 163°C. Found, %: C 27,12; N 3,16; N 5,94. C10H15N2O6S2NaZn.2H2O. Calculated, %:C 26,82; N 3,38; N 6,26.

Example 27. N-Acetyl-L-cysteinato(nicotinate)zinc(II) disabilitati.

Mix 2,32 g N-acetyl-L-cysteine, 1,75 g nicotinate and 3.12 g of the acetate of zinc(II) dihydrate in 25 ml of water and stirred at a temperature of 60°1.5-2 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output, 5,65 So different. 195°C. Found, %: C 32,96; N Is 3.21; N 7,21. C11H13N2O5S2Zn.2,5H2O. Calculated, %: C Represented 33.47 Per; N. Of 3.06; N 7,10.

Example 28. Sodium N-Acetyl-L-cysteinato(nicotinate)zinc(II) tetrahydrate.

Mix 2.17 g of N-acetyl-L-cysteine, 1.64 g of nicotinate and of 2.92 g of the acetate of zinc(II) dihydrate in 20 ml of water at 18-20°With, then gradually under stirring to relax the Ute 0.71 g sodium, raise the temperature of the reaction mixture to 60°C and stirred at this temperature for 1.5 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 5,88 was So different. 82°C. Found, %: C 29,49; N Is 2.74; N 6,18. C11H11N2O5SNaZn.4H2O. Calculated, %: C 29,78; H 2,50; N Of 6.31.

Example 29. Sodium N-acetyl-L-cysteinato (nicotinate)the chlor-zinc(II) tetracampidae.

Mix 1.88 g of N-acetyl-L-cysteine, 1.42 g of nicotinate, of 0.68 g of sodium chloride and of 2.53 g of the acetate of zinc(II) dihydrate in 15 ml of water at 18-20°With, then gradually added with stirring and 0.61 g of sodium, increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 1.5 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. The yield of 5.68, So different. 163°C. Found, %: C 26,87; N 2,85; Cl 7,16; N 5,47. C11H12N2O5SNaZn. 4,5H2O. Calculated, %: 27,01; N 2,47; Cl 7,25; N5,73.

Example 30. Disodium nicotinate(N-acetyl-L-cysteinato)zinc(II) pentahydrate.

Mix of 2.05 g of N-acetyl-L-cysteine, 1.55 g of nicotinate and 2.76 g of the acetate of zinc(II) dihydrate in 15 ml of water at 18-20°With, then gradually added with stirring to 1.33 g of sodium, increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 2 hours. Distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output between 6.08, Try the L. 230°C. Found, %: C 26,95; N 2,41; N 5,64. C11H11N2O5SNa2Zn. 5H2O. Calculated, %: C 27,26; N To 2.29; N 5,78.

Example 31. N-Acetyl-L-cysteinato(nicotinate)zinc(II) sulfate octahydrate.

Mix 1,82 g N-acetyl-L-cysteine, 1,38 g nicotinate and 3.21 g of zinc sulfate(II) katakata in 15 ml of water and stirred at a temperature of 60°1.5-2 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 6,57, So different. 132°C. Found, %: C 22,51; N 1,96; N to 4.52. C11H14N2O9S2Zn.8H2O. Calculated, %: 22,32; N. Of 2.38; N 4,73.

Example 32. N-Acetyl-L-cysteinato(nicotinate)zinc(II) sulfate toilet octahedral.

Mix of 1.32 g of N-acetyl-L-cysteine, 0,99 g nicotinate, 1,53 g of the hydrate p-toluenesulfonic acid and 2,31 g of zinc sulfate(II) katakata in 15 ml of water and stirred at a temperature of 60°1.5-2 hours. Then distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. The yield of 6.02, So different. 179°C. Found, %: C 28,64; N 3,05; N 3,74. C18H22N2O12S3Zn.7H2O. Calculated, %: C 28,98; N 2,97; N 4,75.

Example 33. N-Acetyl-L-cysteine(L-ascorbate)vanadium(IV) sesquihydrate.

Mix of 1.39 g of N-acetyl-L-cysteine, 2,02 g of L-ascorbate and 0.95 g of vanadium oxide(IV) dihydrate in 15 ml of water at 18-20°With, then increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 1.5 hours Distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 4.26 deaths, So different. above 146°C. Found, %: C 29,41; N 3,12; N 3,94. C9H11NO8SV.1,5H2O. Calculated, %: C 29,12; N 2,99; N Of 3.77.

Example 34. N-Acetyl-L-cysteine(L-ascorbate)chromium(III) tetracampidae.

Mix of 1.39 g of N-acetyl-L-cysteine, 2,02 g of L-ascorbate and of 1.65 g of chromium acetate(III) (chromium content 36,15%) in 15 ml of water at 18-20°With, then increase the temperature of the reaction mixture to 60°C and stirred at this temperature for 1.5 hours. Distilled water under vacuum (10-15 Torr) and bring the residue to constant weight. Output 4,88, Trasl. above 142°C. Found, %: C 24,99; N. Of 2.83; N 3,11. C9H12NO8SCr.4,5H2O. Calculated, %: 25,30; N. Of 2.83; N 3,28.

These compounds were subjected to biological tests on experimental models of stress reactions that occur in extreme situations. As such, were selected increased physical activity, which should be overcome by the person or in intense sports activities, either in an emergency or other dangerous situations. This option stress response was simulated on the model of running animals (mice) along the endless track (treadmill) or model in a swimming pool. The second variant of the stress response - the extreme situation caused by the lack of molecular oxygen at departure animal organism vital functions. Often, for various reasons (period rehabilit the tion after severe illness, the specifics of the performance of professional duties and the like) have to operate in conditions of physical inactivity. This type of stress response was also symitirovan on animal model. In addition, some compounds were tested on the model of the stress response, is complicated by additional factors (vibration, hypercapnia, and so on). The results of the tests are summarized in tables No. 1-11 and one drawing. As can be seen from the tables, the tested compounds have characteristic physiologically compatible compounds modulating (with the change of the sign of the effect) the nature of the manifestation of biological activity, as dependent on the structure of the compound and dose.

Sources of information

1. E.A.Parfenov, G.E.Zaikov. Biometals and Ligands for Anticancer Drug Design: Molecular Mechanisms of Superoxide Dismutase Models Antitumor Effects // Nova Science Publishers. - New York. - 1998. - P.380.

2. E.A.Parfenov, G.E.Zaikov. Biometals and Ligands for Anticancer Drug Design: Superoxide Dismutase Models for Combined Tumor Therapy // Nova Science Publishers. - New York. - 2001. - P.278.

3. E.A.Parfenov, G.E.Zaikov. Biotic Type Antioxidants: The Perspective of the Search Area of Novel Chemical Drugs // VSP. - Utrecht-Boston-Tokyo. - 2000. - P. 559.

4. Patent USA No. 13947, class a 61 K 31/198, 2003.

Table 2
The effect of tested compounds on the duration of the voyage mice in standard the conditions
Example Connection name Dose, mg/kg The duration of the voyage as a percent of control
0,5 115±4
1 120±4
1 Bis(N-acetyl-L-cysteinato)cobalt(III)trihydrate 5 164±4
10 154±4
25 117±b
0,5 125±3
1 149±4
5 155±2
2 Bis(N-acetyl-L-cysteinato)iron(II)pentahydrate) 10 175±3
25 163±3
50 142±5
100 122±6
Drugs comparison The bemythyl 50 124±2
100 134±3
Bromantan 50 128±3
100 118±2

Table 4
Comparative effects of bis(N-acetyl-L-cysteinato)equating(II) disabilitato on the survival of different species of animals under conditions of acute hypoxia with hypercapnia intraperitoneal dose of 50 mg/kg
Example Animal The time of survival in the experiment, minutes The time of survival of the control group, minutes The increase in survival time
1 Mouse 210 35 ×6
2 Cats 275 98 ×2,8
Table 5
The effect of tested compounds on rectal temperature in mice
Example Connection name Rectal temperature (°)
1 Bis(-acetyl-L-cysteinato)equating(II) dissemi-hydrate 31,02+0,66
Control 37,06+0,11

Table 7.
Comparative effects of bis(N-acetyl-L-cysteinato)equating(II) disabilitato in comparison with known antihypoxants on the survival of mice in acute hypobaric hypoxia
Substance Dose, mg/kg The lifespan of mice (min); n=8 P (compared with control)
Antizol 25 7,1+0,9 p<0,025
Azizol 10 9,7+1,6 p<0,025
Mexidol 100 4,6+0,05 p>0,05
Bis(N-acetyl-L-cysteinato)equating(II) disabilitati 50 17,9+3,1 p<0,005
Control - 4,4+0,02 -

Table 10
Anti-inflammatory activity of the compounds of aminothiols
Connection aminothiol Carrageenophyte swelling of the paws of rats (inhibition %)
Bis(N-acetyl-L-cysteinato)equating(II)disabilitati 15,90
Bis(2-methyl-5-ethyl-3-hydroxypyridine) bis(N-acetyl-L-cysteinato)-acculturation(IV)tetracampidae 28,40
Bis(N-acetyl-L-cysteinato)acculturation(IV) -56,10

1. Derivatives aminothiols General formula I

Katm+[L1qL2]Ann·p.Solv,

where L1- aminothiol R1NHCH(R2)(CH2)1-2SR3where R1is hydrogen, alkyl With1-20or the group RCO, R is alkyl (C1-19; R2is hydrogen or carboxyl, R3is hydrogen, alkyl With1-20alkenyl2-20or benzyl, and q can take values 1, 2 or 3;

L2- halogen, water and/or organic ligand from among substituted by one or two alkilani1-20; one or two hydroxy or oxymethylene groups, pyridine, hydroxy coumarin derivatives, nicotinic, p-aminobenzoic, phenylacetic acid, or ascorbic acid, or arginine, or missing;

E - Cu (I), CA (II), Co (II), Cu (II), Fe (II), Mn (II), Ni (II), Zn (II), Co (III), Cr (III), Ge (IV), Ti (IV), V (IV);

Kat is missing and who and presents a cation 2-ethyl-6-methyl-3-hydroxypyridine or inorganic cation of an alkaline or alkaline earth metal;

An - is absent or represented by the anion of p-toluenesulfonic acid or sulfate;

Solv - water;

R can take values from 0 to 8.5;

m can take values from 0 (with the exception of compound I, where R1- CH3CO., R2- COO, L2- no, n=0, p=0) to 2;

n can take values from 0 to 3.

2. Derived aminothiol General formula I according to claim 1, where L1- N-acetyl-L-cysteine; L2-water, e-Zn (II), q=2; p=2,5; m=n=0.

3. Derived aminothiol General formula I according to claim 1, where L1- N-acetyl-L-cysteine; L2- no, uh - Fe (II); q=2; p=5; m=n=0.

4. Derived aminothiol General formula I according to claim 1, where L1- N-acetyl-L-cysteine; L2- no, uh - Zn (II), q=2; An - sulfate; p=8; m=0; n=2.

 

© 2013-2015 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.